Ingleby, K.
94  Ergebnisse:
Personensuche X
?
 
?
5

Cost-utility analysis of adding abiraterone acetate plus pr..:

Clarke, Caroline S ; Hunter, Rachael M ; Gabrio, Andrea...
Clarke , C S , Hunter , R M , Gabrio , A , Brawley , C D , Ingleby , F C , Dearnaley , D P , Matheson , D , Attard , G , Rush , H L , Jones , R J , Cross , W , Parker , C , Russell , J M , Millman , R , Gillessen , S , Malik , Z , Lester , J F , Wylie , J , Clarke , N W , Parmar , M K B , Sydes , M R & James , N D 2022 , ' Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England : Lifetime decision model based on STAMPEDE trial data ' , PLOS ONE , vol. 17 , no. 6 , e0269192 . https://doi.org/10.1371/journal.pone.0269192.  , 2022
 
?
7

Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Surv..:

James, N. D ; Ingleby, F. C ; Clarke, N. W...
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35877084/.  , 2022
 
?
8

Micro-fabricated caesium vapor cell with 5 mm optical path ..:

Dyer, T ; Ingleby, S.J ; Dunare, C...
https://strathprints.strath.ac.uk/83292/1/Dyer_etal_JAP_2022_Micro_fabricated_caesium_vapour_cell_with.pdf.  , 2022
 
?
 
?
10

Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Surv..:

James, Nicholas D ; Ingleby, Fiona C ; Clarke, Noel W...
James , N D , Ingleby , F C , Clarke , N W , Amos , C L , Attard , G , Brawley , C D , Chowdhury , S , Cross , W , Dearnaley , D P , Gilbert , D C , Gillessen , S , Jones , R J , Langley , R E , Macnair , A , Malik , Z I , Mason , M D , Matheson , D J , Millman , R , Parker , C C , Rush , H L , Russell , J M , Au , C , Ritchie , A W S , Mestre , R P , Ahmed , I , Birtle , A J , Brock , S J , Das , P , Ford , V A , Gray , E K , Hughes , R J , Manetta , C B , McLaren , D B , Nikapota , A D , O'Sullivan , J M , Perna , C , Peedell , C , Protheroe , A S , Sundar , S , Tanguay , J S , Tolan , S P , Wagstaff , J , Wallace , J B , Wylie , J P , Zarkar , A , Parmar , M K B & Sydes , M R 2022 , ' Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial ' , JNCI Cancer Spectrum , vol. 6 , no. 4 , pkac043 . https://doi.org/10.1093/jncics/pkac043.  , 2022
 
?
11

Cost-utility analysis of adding abiraterone acetate plus pr..:

Caroline S. Clarke ; Rachael M. Hunter ; Andrea Gabrio...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162346/?tool=EBI.  , 2022
 
1-15